Researchers report findings of a blood biomarker that consistently detects mild to moderate traumatic brain injury (MMTBI) for up to 7 days and quantifies the degree of damage.
“This test could take the guesswork out of making a diagnosis by allowing doctors to simply look for a specific biomarker in the blood”, lead researcher Linda Papa (Orlando Regional Medical Center, Florida, USA) told the press.
The biomarker is glial fibrillary acidic protein (GFAP) and is found in the astroglial skeleton of both white and grey brain matter.
